164 related articles for article (PubMed ID: 2504875)
1. Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice.
Yukawa K; Kikutani H; Inomoto T; Uehira M; Bin SH; Akagi K; Yamamura K; Kishimoto T
J Exp Med; 1989 Sep; 170(3):711-26. PubMed ID: 2504875
[TBL] [Abstract][Full Text] [Related]
2. Strain-dependency of chromosomal abnormalities in lymphomas developed in E mu-myc transgenic mice.
Akagi K; Yamamura K
Jpn J Cancer Res; 2001 May; 92(5):499-505. PubMed ID: 11376558
[TBL] [Abstract][Full Text] [Related]
3. The transgenic window on lymphoid malignancy.
Adams JM; Harris AW; Vaux DL; Alexander WS; Rosenbaum H; Klinken SP; Strasser A; Bath ML; McNeall J; Cory S
Princess Takamatsu Symp; 1989; 20():297-309. PubMed ID: 2518688
[TBL] [Abstract][Full Text] [Related]
4. Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice.
Alexander WS; Schrader JW; Adams JM
Mol Cell Biol; 1987 Apr; 7(4):1436-44. PubMed ID: 3037318
[TBL] [Abstract][Full Text] [Related]
5. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
[TBL] [Abstract][Full Text] [Related]
6. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.
Nussenzweig MC; Schmidt EV; Shaw AC; Sinn E; Campos-Torres J; Mathey-Prevot B; Pattengale PK; Leder P
Nature; 1988 Dec; 336(6198):446-50. PubMed ID: 3143076
[TBL] [Abstract][Full Text] [Related]
7. Strain dependency of cell-type specificity and onset of lymphoma development in Emu-myc transgenic mice.
Akagi K; Miyazaki J; Yamamura K
Jpn J Cancer Res; 1992 Mar; 83(3):269-73. PubMed ID: 1582889
[TBL] [Abstract][Full Text] [Related]
8. IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis.
Möröy T; Fisher P; Guidos C; Ma A; Zimmerman K; Tesfaye A; DePinho R; Weissman I; Alt FW
EMBO J; 1990 Nov; 9(11):3659-66. PubMed ID: 2120050
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.
Schmidt EV; Pattengale PK; Weir L; Leder P
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6047-51. PubMed ID: 3261863
[TBL] [Abstract][Full Text] [Related]
10. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
[TBL] [Abstract][Full Text] [Related]
11. N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc.
Rosenbaum H; Webb E; Adams JM; Cory S; Harris AW
EMBO J; 1989 Mar; 8(3):749-55. PubMed ID: 2785918
[TBL] [Abstract][Full Text] [Related]
12. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.
Langdon WY; Harris AW; Cory S; Adams JM
Cell; 1986 Oct; 47(1):11-8. PubMed ID: 3093082
[TBL] [Abstract][Full Text] [Related]
13. IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression.
Dildrop R; Ma A; Zimmerman K; Hsu E; Tesfaye A; DePinho R; Alt FW
EMBO J; 1989 Apr; 8(4):1121-8. PubMed ID: 2501083
[TBL] [Abstract][Full Text] [Related]
14. E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells.
Strasser A; Harris AW; Cory S
Oncogene; 1993 Jan; 8(1):1-9. PubMed ID: 8423986
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.
Lovec H; Grzeschiczek A; Kowalski MB; Möröy T
EMBO J; 1994 Aug; 13(15):3487-95. PubMed ID: 8062825
[TBL] [Abstract][Full Text] [Related]
16. High frequency of myelomonocytic tumors in aging E mu L-myc transgenic mice.
Möröy T; Fisher PE; Lee G; Achacoso P; Wiener F; Alt FW
J Exp Med; 1992 Feb; 175(2):313-22. PubMed ID: 1310099
[TBL] [Abstract][Full Text] [Related]
17. Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice.
Suda Y; Aizawa S; Hirai S; Inoue T; Furuta Y; Suzuki M; Hirohashi S; Ikawa Y
EMBO J; 1987 Dec; 6(13):4055-65. PubMed ID: 2832150
[TBL] [Abstract][Full Text] [Related]
18. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
19. Immunologic competence of B cells subjected to constitutive c-myc oncogene expression in immunoglobulin heavy chain enhancer myc transgenic mice.
Vaux DL; Adams JM; Alexander WS; Pike BL
J Immunol; 1987 Dec; 139(11):3854-60. PubMed ID: 2445821
[TBL] [Abstract][Full Text] [Related]
20. Hemopoietic neoplasms in lethally irradiated mice repopulated with bone marrow cells carrying the human c-myc oncogene: a repopulation assay.
Hirabayashi Y; Inoue T; Suda Y; Aizawa S; Ikawa Y; Kanisawa M
Exp Hematol; 1992 Feb; 20(2):167-72. PubMed ID: 1544384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
